[go: up one dir, main page]

NO965444L - Triterpen-derivat samt medikamentell sammensetning omfattende dette - Google Patents

Triterpen-derivat samt medikamentell sammensetning omfattende dette

Info

Publication number
NO965444L
NO965444L NO965444A NO965444A NO965444L NO 965444 L NO965444 L NO 965444L NO 965444 A NO965444 A NO 965444A NO 965444 A NO965444 A NO 965444A NO 965444 L NO965444 L NO 965444L
Authority
NO
Norway
Prior art keywords
substituted
well
drug composition
alkinyl
cycloalkyl
Prior art date
Application number
NO965444A
Other languages
English (en)
Other versions
NO965444D0 (no
Inventor
Tadaaki Ohgi
Hiroto Yoshifusa
Kazuhisa Kandori
Original Assignee
Nippon Shinyaku Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nippon Shinyaku Co Ltd filed Critical Nippon Shinyaku Co Ltd
Publication of NO965444D0 publication Critical patent/NO965444D0/no
Publication of NO965444L publication Critical patent/NO965444L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J63/00Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by expansion of only one ring by one or two atoms
    • C07J63/008Expansion of ring D by one atom, e.g. D homo steroids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J71/00Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0005Oxygen-containing hetero ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)

Abstract

Oppfinnelsen vedrører et hederageninderivat med den følgende formel eller et farmasøytisk akseptabelt salt derav samt en farmasøytisk sammensetning som inneholder denne forbindelse som en aktiv ingrediens. (hvor R1 betyr OR11 eller NR1:LR12; R11 og R12 kan være like eller forskjellige, og hver av dem betyr hydrogen, alkyl som kan være substituert, cykloalkyl som kan være substituert, alkenyl som kan være substituert, alkinyl som kan være substituert, aryl som kan være substituert eller en heteroaromatisk gruppe som kan være substituert; R2 og R3 kan være like eller forskjellige, og hver av dem betyr hydrogen, alkyl som kan være substituert, cykloalkyl som kan være substituert, alkenyl som kan være substituert, alkinyl som kan være substituert, acyl som kan være substituert , monoalkylkarbamoyl som kan være substituert, dialkylkarbamoyl som kan være substituert eller alkoksykarbonyl som kan være substituert, eller R2 og R3 sammen betyr karbonyl . ) Den farmasøytiske sammensetning ifølge oppfinnelsen er virksom ved behandling av nefritt.
NO965444A 1994-06-24 1996-12-18 Triterpen-derivat samt medikamentell sammensetning omfattende dette NO965444L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP14270894 1994-06-24
PCT/JP1995/001249 WO1996000236A1 (en) 1994-06-24 1995-06-22 Triterpene derivative and medicinal composition

Publications (2)

Publication Number Publication Date
NO965444D0 NO965444D0 (no) 1996-12-18
NO965444L true NO965444L (no) 1997-02-24

Family

ID=15321726

Family Applications (1)

Application Number Title Priority Date Filing Date
NO965444A NO965444L (no) 1994-06-24 1996-12-18 Triterpen-derivat samt medikamentell sammensetning omfattende dette

Country Status (12)

Country Link
US (1) US5885992A (no)
EP (1) EP0767177A4 (no)
CN (1) CN1151165A (no)
AU (1) AU2753095A (no)
BR (1) BR9508110A (no)
CA (1) CA2193679A1 (no)
FI (1) FI965193A0 (no)
HU (1) HUT76333A (no)
MX (1) MX9606493A (no)
NO (1) NO965444L (no)
TW (1) TW403759B (no)
WO (1) WO1996000236A1 (no)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19616538B4 (de) * 1996-04-25 2004-02-12 Lucas Industries Plc, Solihull Elektrohydraulische Bremsanlage
US6124362A (en) * 1998-07-17 2000-09-26 The Procter & Gamble Company Method for regulating hair growth
US9387168B2 (en) 1999-09-20 2016-07-12 Jack Barreca Chewing gum with tomatidine
AU2000235744A1 (en) * 2000-02-29 2001-09-12 Dabur Research Foundation A novel process for manufacturing betulinic acid from ziziphus jujuba
GB0128071D0 (en) * 2001-11-22 2002-01-16 Cyclacel Ltd Medicament
CA2497161A1 (en) * 2002-08-28 2004-03-11 Lupin Ltd. Herbal extract comprising a mixture of saponins obtained from sapindus trifoliatus for anticonvulsant activity
WO2005021435A2 (en) * 2003-02-25 2005-03-10 Emory University Compositions materials incorporating the compositions, and methods of using the compositions and materials
JP2007525601A (ja) 2003-05-08 2007-09-06 テファ, インコーポレイテッド ポリヒドロキシアルカノエート医療用織物および医療用繊維
US11090313B2 (en) 2010-05-20 2021-08-17 University Of Iowa Research Foundation Methods for inhibiting muscle atrophy
CN104688745B (zh) * 2010-05-20 2019-11-12 爱荷华大学研究基金会 用于抑制肌萎缩的方法
EP3301105B1 (en) * 2010-07-16 2020-04-15 Pacific Arrow Limited New oleanane-24-esters for treating cancer and other diseases
JP6001060B2 (ja) 2011-06-06 2016-10-05 ユニバーシティ オブ アイオワ リサーチ ファウンデーション 筋萎縮を阻害するための方法
WO2013028307A1 (en) * 2011-08-24 2013-02-28 Amyris, Inc. Derivatives of hydrocarbon terpenes
CN102659905B (zh) * 2012-05-21 2014-07-30 广州博济医药生物技术股份有限公司 一种常春藤皂苷元衍生物及其制备方法和应用
CN102675406A (zh) * 2012-06-04 2012-09-19 福州大学 抗肿瘤活性的熊果酸含氮杂环类结构修饰物及其制备方法
WO2016193309A1 (en) * 2015-06-01 2016-12-08 Dsm Ip Assets B.V. New bis esters of ivy sapogenins for ruminants

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH06345650A (ja) * 1993-06-14 1994-12-20 Suntory Ltd ヘデラゲニン化合物を有効成分とする骨疾患の予防及び治療剤

Also Published As

Publication number Publication date
WO1996000236A1 (en) 1996-01-04
HUT76333A (en) 1997-08-28
EP0767177A1 (en) 1997-04-09
CA2193679A1 (en) 1996-01-04
US5885992A (en) 1999-03-23
BR9508110A (pt) 1997-08-12
CN1151165A (zh) 1997-06-04
FI965193A7 (fi) 1996-12-23
EP0767177A4 (en) 1998-09-30
FI965193A0 (fi) 1996-12-23
HU9603487D0 (en) 1997-02-28
TW403759B (en) 2000-09-01
AU2753095A (en) 1996-01-19
MX9606493A (es) 1997-03-29
NO965444D0 (no) 1996-12-18

Similar Documents

Publication Publication Date Title
NO965444L (no) Triterpen-derivat samt medikamentell sammensetning omfattende dette
RU2221790C2 (ru) Новые производные пиридазина и лекарственные средства, содержащие их в качестве эффективных ингредиентов
ATE273958T1 (de) Heterocyclische verbindungen als h+-atpasen
GEP20053421B (en) Substituted Pyrazoles As P38 Kinase Inhibitors, Method for Their Production and Pharmaceutical Compositions Containing Them
MY101359A (en) 7-acylamino-3-vinylcephalosporanic acid derivatives, processes for their preparation, pharmaceutical compositions containing them, their starting compounds and their preparation
HUP0001062A2 (hu) NAALADáz gátló hatású foszfinsavszármazékokat tartalmazó gyógyászati készítmények
DE69723869D1 (de) Heterozyklische verbindungen, verfahren zu ihrer herstellung, pharmazeutische zusammensetzungen die diese enthalten und ihre anwendung in der behandlung von diabetis und verwandten krankheiten
IL97025A0 (en) 17beta-substituted-4-aza-5alpha-androstan-3-one derivatives,their preparation and pharmaceutical compositions containing them
CA2126337A1 (en) 2-amino-1,3-propanediol compound and immunosuppressant
ATE197672T1 (de) Arzneimittel gegen nervöse erkrankungen
RU95108243A (ru) Производные амидов вальпроновой и 2-вальпроеновой кислоты, фармацевтическая композиция, способы лечения
PL312196A1 (en) Heterocyclic phenyl compounds as inhibitors of cyclooxygenase-2
EP0670309A4 (en) RELATED TO PROLYE-ENDOPEPTIDASE INHIBITING ACTIVITY AND THEIR PHARMACEUTICAL USE.
HU9500240D0 (en) New prolin-amide derivatives and pharmaceutical compositions containing them as active component
DK0750618T3 (da) Oxazolidinonderivater og farmaceutiske præparater indeholdende dem
RU94044436A (ru) Способы подавления атрофии кожи и влагалища
MY132473A (en) Crystalline hydrochloride of (r)-(-)-2-<n-[4-(1,1- dioxido-3-oxo-2,3-dihydro-benzisothiazol-2-yl)-butyl]-aminomethyl>-chroman
WO2002051819A3 (en) Heterocyclic compounds having antibacterial activity, process for their preparation and pharmaceutical compositions containing them
RU94036772A (ru) Применение 2-фенил-3-ароилбензотиофенов для ингибирования эндометриоза
FR2705343B1 (fr) Dérivés de beta,beta-diméthyl-4-pipéridineéthanamine, leur procédé de préparation et leur utilisation en thérapeutique.
BG103426A (en) Derivatives of substituted 4-biphenyl-4-hydroxy-oil acids as inhibitors of matrix metalloproteases
CA2211128A1 (en) Epoxysuccinamide derivatives or salts thereof, and drugs containing the same
HUP9802897A2 (hu) Optikailag aktív piridil-4H-1,2,4-oxadiazin-származék, annak alkalmazása vaszkuláris betegségek kezelésére, valamint ilyen származékot hatóanyagként tartalmazó gyógyászati készítmény
DE69815509D1 (de) Heterozyklische verbindungen die als oxido-squalen-zyklase-inhibitoren anwendung finden
CA2382654A1 (en) Novel a-500359 derivatives